Elizabeth J. Hovey

Barker Street
Randwick, NSW 2031, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Dose-dependent neurotoxic chemotherapy and corneal nerve morphological changes.

Dose-dependent neurotoxic chemotherapy and corneal nerve morphological changes.

Journal: Clinical & experimental optometry

Published: January 22, 2026

Region-Based Analyses of Existing Genome-Wide Association Studies Identifies Novel Potential Genetic Susceptibility Regions for Glioma.

Region-Based Analyses of Existing Genome-Wide Association Studies Identifies Novel Potential Genetic Susceptibility Regions for Glioma.

Journal: Cancer research communications

Published: July 17, 2024

A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma.

A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma.

Journal: BJU international

Published: November 21, 2023

Estimated incidence of disruptions to event-free survival from non-metastatic cancers in New South Wales, Australia - a population-wide epidemiological study of linked cancer registry and treatment data.

Estimated incidence of disruptions to event-free survival from non-metastatic cancers in New South Wales, Australia - a population-wide epidemiological study of linked cancer registry and treatment data.

Journal: Frontiers in oncology

Published: November 17, 2023

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.

Journal: Neuro-oncology advances

Published: October 16, 2023

Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502).

Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502).

Journal: European urology oncology

Published: May 25, 2023

A practical guide for the use of apalutamide for non-metastatic castration-resistant prostate cancer in Australia.

A practical guide for the use of apalutamide for non-metastatic castration-resistant prostate cancer in Australia.

Journal: Asia-Pacific journal of clinical oncology

Published: March 08, 2023

Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26.

Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26.

Journal: Neuro-oncology

Published: December 21, 2022

Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study.

Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study.

Journal: BMJ supportive & palliative care

Published: December 07, 2022

Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT).

Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT).

Journal: Therapeutic advances in medical oncology

Published: September 16, 2022

Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma.

Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma.

Journal: BMJ open

Published: September 14, 2022

Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy.

Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy.

Journal: Asia-Pacific journal of clinical oncology

Published: March 30, 2022

Showing 1-12 of 55

Last Updated: 09/26/2026